Repeating 8 Gy Single Fraction Radiation Therapy
A single 8 Gy fraction can be repeated after 1 week in patients who respond or have stable disease, based on established clinical practice for palliative bone metastases and spinal cord compression. 1
Evidence for 1-Week Interval
The most direct evidence comes from a prospective study of metastatic spinal cord compression where 8 Gy was repeated after exactly 1 week in responders or stable patients, achieving a total dose of 16 Gy with good clinical outcomes and minimal toxicity. 1 This regimen demonstrated:
- 67% pain relief rate 1
- 63% motor function response rate 1
- No evidence of relapse in the irradiated spine 1
- Only slight side effects, primarily mild esophagitis 1
Clinical Context for Re-treatment Timing
For palliative bone metastases specifically, the ESMO guidelines establish that 8 Gy single dose is the recommended regimen of choice, with the understanding that re-treatment may be necessary. 2 The evidence shows:
- Re-treatment rates are approximately 20% after 8 Gy single fraction (compared to 8% after fractionated regimens) 3
- This higher re-treatment rate reflects greater readiness to prescribe radiotherapy after a single fraction, not greater need 3
- Pain relief from 8 Gy is equivalent to multi-fraction regimens for at least 12 months 3
Practical Algorithm for Re-treatment Decision
Assess response at 1 week:
- If responding or stable → repeat 8 Gy (total 16 Gy) 1
- If progressing → consider alternative fractionation or systemic therapy 1
For subsequent re-treatments beyond the initial repeat:
- Allow sufficient time for pain assessment (typically 2-4 weeks for full effect) 3
- Consider that pain relief may not appear for 10-14 days after palliative radiation 2
- Re-treatment to the same site is feasible and safe when clinically indicated 3
Important Caveats
Normal tissue tolerance considerations:
- Rapidly proliferating tissues recover well and tolerate re-irradiation to almost full doses 4
- Slowly proliferating tissues (lung, spinal cord) can tolerate re-irradiation with reduced doses after 3-6 months 4
- The 1-week interval for repeating 8 Gy is specifically validated for palliative settings, not definitive treatment 1
Patient selection matters:
- This short-course approach is particularly appropriate for patients with poor performance status, short life expectancy, or low radio-responsive tumors 1
- Medium-dose dexamethasone (8 mg twice daily) should be given concurrently 1
- Prophylactic antiemetics are recommended when fields cover the upper abdomen 1